Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Antibiotics and Affect: Avenues for Addiction Management
Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...
Affordable 3D-Printed Neural Devices for Spinal Cord Regeneration
Medical treatments for spinal cord injuries are expensive and difficult to test. I want to try to develop...
Community-based Leishmaniasis research in Sri Lanka
Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...